15

General Information


DRACP ID  DRACP04815

Peptide Name   15

Sequence  YSXG

Sequence Length  4

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  X=Cα -dialkylated glycine (Aaa2,2 )

Chiral  L



Physicochemical Information


Formula  C14H17N3O5

Absent amino acids  ACDEFHIKLMNPQRTVW

Common amino acids  GSYX

Mass  47099

Pl  6.09

Basic residues  0

Acidic residues  0

Hydrophobic residues  0

Net charge  0

Boman Index  -260

Hydrophobicity  -62.5

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  1490

Absorbance 280nm  496.67

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 16722632

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




CancerPPD ID  3917

CancerPPD ID  3918

CancerPPD ID  3919

CancerPPD ID  3920

CancerPPD ID  3921

CancerPPD ID  3922

CancerPPD ID  3923

CancerPPD ID  3924

CancerPPD ID  3925

CancerPPD ID  3926

CancerPPD ID  3927

CancerPPD ID  3928

CancerPPD ID  3929

CancerPPD ID  3930

CancerPPD ID  3931

CancerPPD ID  3932

CancerPPD ID  3933

CancerPPD ID  3934

CancerPPD ID  3935

CancerPPD ID  3936

CancerPPD ID  3937

CancerPPD ID  3938

CancerPPD ID  3939

CancerPPD ID  3940

CancerPPD ID  3941

DRACP is developed by Dr.Zheng's team.